EMERYVILLE, Calif.,
Feb. 25, 2021 /PRNewswire/ -- Amyris,
Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company
active in the Clean Health and Beauty markets through its consumer
brands, today announced that members of its management team will
participate in two upcoming investor conferences:
- Cowen 41st Annual Health Care Conference,
March 4 at 12:10 PM ET
- H.C. Wainwright Global Life Sciences Conference, March 9 at 1:30 PM
ET
A webcast of the presentations and replays will be available on
the Investor Relations section of the company's website
at http://investors.amyris.com.
About Amyris
Amyris (Nasdaq: AMRS) is a science and
technology leader in the research, development and production of
sustainable ingredients for the Clean Health & Beauty and
Flavors & Fragrances markets. Amyris uses an impressive array
of exclusive technologies, including state-of-the-art machine
learning, robotics and artificial intelligence. Our ingredients are
included in over 3,000 products from the world's top brands,
reaching more than 200 million consumers. Amyris is proud to own
three consumer brands - all built around its No Compromise® promise
of clean ingredients: Biossanceâ clean beauty skincare,
Pipetteâ clean baby skincare and Purecane™, a zero-calorie
sweetener naturally derived from sugarcane. For more information,
please visit www.amyris.com.
Amyris, the Amyris logo, No Compromise, Biossance, Pipette, and
Purecane are trademarks or registered trademarks of Amyris, Inc. in
the U.S. and/or other countries.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/amyris-announces-participation-in-upcoming-investor-conferences-301235429.html
SOURCE Amyris, Inc.